43 results
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... known to have HIV ... diagnosed with HIV ... 3 years • Co-testing ... HumanPapillomavirus #IDSA
FABER (Patrick's) Test for Hip and Sacroiliac Pathology

Patrick's or Faber Test can be performed to evaluate
FABER (Patrick's ... Sacroiliac Pathology Patrick's ... rotated in position, resting ... parallel to the exam table ... PT_yuu_mizu628 #FABER #Patricks
FABER (Patrick's) Test for Hip and Sacroiliac Pathology

Patrick's or Faber Test can be performed to evaluate
FABER (Patrick's ... Sacroiliac Pathology Patrick's ... rotated in position, resting ... parallel to the exam table ... PT_yuu_mizu628 #FABER #Patricks
FABER (Patrick's) Test for Hip and Sacroiliac Pathology

Patrick's or Faber Test can be performed to evaluate
FABER (Patrick's ... Sacroiliac Pathology Patrick's ... rotated in position, resting ... parallel to the exam table ... open_michigan #FABER #Patricks
FABER (Patrick's) Test for Hip and Sacroiliac Pathology

Patrick's or Faber Test can be performed to evaluate
FABER (Patrick's ... Sacroiliac Pathology Patrick's ... rotated in position, resting ... parallel to the exam table ... PT_yuu_mizu628 #FABER #Patricks
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... Preventing and Treating ... Infections in HIV-AIDS ... PO (or 400 mg IV ... Enteric #Bacterial #IDSA
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... for Treating Mucosal ... Candidiasis in HIV-AIDS ... mucoadhesive buccal tablet ... chew, or crush tablet
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Preventing and Treating ... Infections in HIV-AIDS ... to 5 mg/kg/day IV ... Penicilliosis #IDSA
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... for Treating Visceral ... Leishmaniasis in HIV-AIDS ... Treating Visceral ... every 21 days Treating
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... for Treating Herpes ... Infections in HIV-AIDS ... Treating Orolabial ... #IDSA #Prevention